[1]
“Evaluation Of Azilsartan Transdermal Hydrogel In Volumetric Muscle Loss Injury In A Rat Model”, Journal of Pharmaceutical Negative Results, vol. 13, pp. 2517–2522, Nov. 2022, doi: 10.47750/pnr.2022.13.S05.389.